Committed to You
Type II Diabetes - Drug Naive

Protenium Clinical Research is taking part in a research study looking at the safety and effectiveness of a new investigational oral medication for treating Type II Diabetes.

If you have Type II Diabetes and are not currently taking any diabetes medication you may be eligible to participate.

Earlier research studies have suggested that the new investigational medication may lower blood sugar levels. This research study will involve 920 patients from approximately 220 clinics in 9 different countries. The study will last for approximately 28 weeks, during which time you will see the study doctor and/or nurse about 8 times.

Qualified participants will receive all study-related care and study medication at no cost, and may be compensated for time and travel.

To receive more information about this study, please take a moment to complete our online survey or you may call us directly at 817-281-4156.

Study volunteers are not required to complete this online survey in order to be considered for participation in this study. The purpose of this online survey is for us to collect your contact information as well as a brief medical history to help determine your eligibility.

All information provided will be considered confidential and will not be shared outside of Protenium Clinical Research.

View our ad for this study
Name
Phone Number
Email
Are you at least 18 years of age?


Have you been diagnosed with Type II Diabetes?


If you have been diagnosed with Type II Diabetes, have you taken any oral or injectable anti-diabetes medication during the past 9 weeks?


Have you undergone any bariatric or gastrointestinal surgeries during the past 2 years?


Have you experienced a myocardial infarction (heart attack), stroke, or transcient ischemic attack (stroke-like symptoms) during the past 3 months?


Please list any medications you are currently taking.
How did you learn about us?









Copyright 2012 © Protenium Clinic Research